Keywords: merck, kgaa, ceo, weighs, up, gsk, antidepressant

Merck KGaA CEO weighs up GSK antidepressant deal

Article | 16 February 2001

Print This

Merck KGaA of Germany has announced a massive 155.6% leap in net incomefor the fourth quarter of 2000 to 81.4 million euros ($75.8 million), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in